Andrew E Place

16PUBLICATIONS
102CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Adolescent healthHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

|Mar 13, 2026
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study.

Daniel A Morgenstern, Giuseppe Barone, Nadege Corradini

|Apr 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.

Seth E Karol, Seong L Khaw, C Michel Zwaan

|Mar 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

Andrew E Place, Seth E Karol, Christopher J Forlenza

|Feb 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial.

Nirali N Shah, Eric S Schafer, Yueh-Yun Chi

|Sep 19, 2023
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.

Jonathan Paolino, Boris Dimitrov, Beth Apsel Winger

Pageof 3

Frequent Collaborators

4 joint publications

Todd M Cooper

4 joint publications

Giacomo Gotti

4 joint publications

Marlise R Luskin

3 joint publications

Maria-Luisa Sulis